Downregulation of astrocyte elevated gene‑1 expression inhibits the development of vasculogenic mimicry in gliomas

Liang,Chen; Shangguan,Jian; Yang,Ling; Guo,Shiwen

doi:10.3892/etm.2020.9454

Downregulation of astrocyte elevated gene‑1 expression inhibits the development of vasculogenic mimicry in gliomas

Authors:
- Chen Liang
- Jian Shangguan
- Ling Yang
- Shiwen Guo
View Affiliations

Affiliations: Department of Neurosurgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China, Department of Aeromedical Physical Examination, Xi'an Civil Aviation Hospital, Xi'an, Shaanxi 710082, P.R. China
Published online on: November 6, 2020 https://doi.org/10.3892/etm.2020.9454
Article Number: 22
Copyright: © Liang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Vasculogenic mimicry (VM) contributes to the resistance of anti‑angiogenic therapies in glioma. Certain genes, including MMP‑2 and VEGF may be associated with the development of VM. Astrocyte elevated gene‑1 (AEG‑1) is considered to be an oncogene that promotes autophagy, invasion, metastasis, angiogenesis and drug resistance; however, the association between AEG‑1 and VM formation is still unknown. The present study investigated the effects of AEG‑1 downregulation on VM formation in the U87 glioma cell line in vitro and in xenograft models of glioma, and the potential underlying mechanisms of action. In the present study, U87 glioma cells were infected with the AEG‑1 short hairpin RNA lentivirus. A Matrigel‑based tube formation assay was performed to evaluate VM formation in vitro. Reverse transcription‑quantitative PCR and western blot analysis were conducted to investigate the mRNA and protein expression levels of MMP‑2 and VEGF. Glioma xenograft models were generated through the intracerebral implantation of U87 glioma cells into nude rats; CD34/Periodic Acid‑Schiff double‑staining was performed to detect VM channels in vivo. Following AEG‑1 downregulation in U87 cells, the development of VM was significantly decreased in vitro and in vivo. In addition, the expression levels of MMP‑2 and VEGF in glioma cells were decreased compared with the control group. These results suggested that downregulation of AEG‑1 expression could significantly inhibit the development of VM in gliomas, both in vitro and in vivo, and may be partially related to the regulation of VEGF and MMP‑2 expression.

View Figures

View References

1	Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C and Barnholtz-Sloan JS: CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. Neuro-oncol. 21 (Suppl 5):v1–v100. 2019.PubMed/NCBI View Article : Google Scholar
2	Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, Taylor LP, Lieberman F, Silvani A, Fink KL, et al: Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA. 314:2535–2543. 2015.PubMed/NCBI View Article : Google Scholar
3	Komori T: The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision. Neurol Med Chir (Tokyo). 57:301–311. 2017.PubMed/NCBI View Article : Google Scholar
4	Ameratunga M, Pavlakis N, Wheeler H, Grant R, Simes J and Khasraw M: Anti-angiogenic therapy for high-grade glioma. Cochrane Database Syst Rev. 11(CD008218)2018.PubMed/NCBI View Article : Google Scholar
5	Blumenthal DT, Kanner AA, Aizenstein O, Cagnano E, Greenberg A, Hershkovitz D, Ram Z and Bokstein F: Surgery for Recurrent High-Grade Glioma After Treatment with Bevacizumab. World Neurosurg. 110:e727–e737. 2018.PubMed/NCBI View Article : Google Scholar
6	El Hallani S, Boisselier B, Peglion F, Rousseau A, Colin C, Idbaih A, Marie Y, Mokhtari K, Thomas JL, Eichmann A, et al: A new alternative mechanism in glioblastoma vascularization: Tubular vasculogenic mimicry. Brain. 133:973–982. 2010.PubMed/NCBI View Article : Google Scholar
7	Chen YS and Chen ZP: Vasculogenic mimicry: A novel target for glioma therapy. Chin J Cancer. 33:74–79. 2014.PubMed/NCBI View Article : Google Scholar
8	Zou M, Zhu W, Wang L, Shi L, Gao R, Ou Y, Chen X, Wang Z, Jiang A, Liu K, et al: AEG-1/MTDH-activated autophagy enhances human malignant glioma susceptibility to TGF-β1-triggered epithelial-mesenchymal transition. Oncotarget. 7:13122–13138. 2016.
9	Noch E, Bookland M and Khalili K: Astrocyte-elevated gene-1 (AEG-1) induction by hypoxia and glucose deprivation in glioblastoma. Cancer Biol Ther. 11:32–39. 2011.PubMed/NCBI View Article : Google Scholar
10	Yang Y, Wu J, Guan H, Cai J, Fang L, Li J and Li M: MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2. FEBS Lett. 586:3608–3612. 2012.PubMed/NCBI View Article : Google Scholar
11	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
12	Liang C, Guo S and Yang L: Effects of all trans retinoic acid on VEGF and HIF 1α expression in glioma cells under normoxia and hypoxia and its anti angiogenic effect in an intracerebral glioma model. Mol Med Rep. 10:2713–2719. 2014.PubMed/NCBI View Article : Google Scholar
13	Francescone RA, Faibish M and Shao R: A matrigel-based tube formation assay to assess the vasculogenic activity of tumor cells. J Vis Exp. 55(e3040)2011.PubMed/NCBI View Article : Google Scholar
14	Hernández de la Cruz ON, López-González JS, García-Vázquez R, Salinas-Vera YM, Muñiz-Lino MA, Aguilar-Cazares D, López-Camarillo C and Carlos-Reyes Á: Regulation networks driving vasculogenic mimicry in solid tumors. Front Oncol. 9(1419)2020.PubMed/NCBI View Article : Google Scholar
15	Haibe Y, Kreidieh M, El Hajj H, Khalifeh I, Mukherji D, Temraz S and Shamseddine A: Resistance Mechanisms to Anti-angiogenic Therapies in Cancer. Front Oncol. 10(221)2020.PubMed/NCBI View Article : Google Scholar
16	Wu HB, Yang S, Weng HY, Chen Q, Zhao XL, Fu WJ, Niu Q, Ping YF, Wang JM, Zhang X, et al: Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells. Autophagy. 13:1528–1542. 2017.PubMed/NCBI View Article : Google Scholar
17	Ge H and Luo H: Overview of advances in vasculogenic mimicry - a potential target for tumor therapy. Cancer Manag Res. 10:2429–2437. 2018.PubMed/NCBI View Article : Google Scholar
18	Xu X, Jia R, Zhou Y, Song X and Fan X: Investigation of vasculogenic mimicry in sebaceous carcinoma of the eyelid. Acta Ophthalmol. 88:e160–e164. 2010.PubMed/NCBI View Article : Google Scholar
19	Zhang Z, Han Y, Zhang K and Teng L: Investigation of vasculogenic mimicry in intracranial hemangiopericytoma. Mol Med Rep. 4:1295–1298. 2011.PubMed/NCBI View Article : Google Scholar
20	Robertson FM, Simeone AM, Lucci A, McMurray JS, Ghosh S and Cristofanilli M: Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4. Cancer. 116 (Suppl):2806–2814. 2010.PubMed/NCBI View Article : Google Scholar
21	Hendrix MJ, Seftor EA, Hess AR and Seftor RE: Vasculogenic mimicry and tumour-cell plasticity: Lessons from melanoma. Nat Rev Cancer. 3:411–421. 2003.PubMed/NCBI View Article : Google Scholar
22	Seftor RE, Seftor EA, Koshikawa N, Meltzer PS, Gardner LM, Bilban M, Stetler-Stevenson WG, Quaranta V and Hendrix MJ: Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res. 61:6322–6327. 2001.PubMed/NCBI
23	Qiao L, Liang N, Zhang J, Xie J, Liu F, Xu D, Yu X and Tian Y: Advanced research on vasculogenic mimicry in cancer. J Cell Mol Med. 19:315–326. 2015.PubMed/NCBI View Article : Google Scholar
24	Hess AR, Seftor EA, Seftor RE and Hendrix MJ: Phosphoinositide 3-kinase regulates membrane type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. Cancer Res. 63:4757–4762. 2003.PubMed/NCBI
25	Liu Y, Li F, Yang YT, Xu XD, Chen JS, Chen TL, Chen HJ, Zhu YB, Lin JY, Li Y, et al: IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma. Oncogene. 38:1815–1831. 2019.PubMed/NCBI View Article : Google Scholar
26	Bai R, Ding T, Zhao J, Liu S, Zhang L, Lan X, Yu Y and Yin L: The effect of PI3K inhibitor LY294002 and gemcitabine hydrochloride combined with ionizing radiation on the formation of vasculogenic mimicry of Panc-1 cells in vitro and in vivo. Neoplasma. 63:80–92. 2016.PubMed/NCBI View Article : Google Scholar
27	Zhang S, Li M, Gu Y, Liu Z, Xu S, Cui Y and Sun B: Thalidomide influences growth and vasculogenic mimicry channel formation in melanoma. J Exp Clin Cancer Res. 27(60)2008.PubMed/NCBI View Article : Google Scholar
28	Wang JY, Sun T, Zhao XL, Zhang SW, Zhang DF, Gu Q, Wang XH, Zhao N, Qie S and Sun BC: Functional significance of VEGF-a in human ovarian carcinoma: Role in vasculogenic mimicry. Cancer Biol Ther. 7:758–766. 2008.PubMed/NCBI View Article : Google Scholar
29	Qin L, Ren Y, Chen AM, Guo FJ, Xu F, Gong C, Cheng P, Du Y and Liao H: Peroxisome proliferator-activated receptor γ ligands inhibit VEGF-mediated vasculogenic mimicry of prostate cancer through the AKT signaling pathway. Mol Med Rep. 10:276–282. 2014.PubMed/NCBI View Article : Google Scholar
30	Mei J, Gao Y, Zhang L, Cai X, Qian Z, Huang H and Huang W: VEGF-siRNA silencing induces apoptosis, inhibits proliferation and suppresses vasculogenic mimicry in osteosarcoma in vitro. Exp Oncol. 30:29–34. 2008.PubMed/NCBI
31	Yu JQ, Zhou Q, Zhu H, Zheng FY and Chen ZW: Overexpression of astrocyte elevated gene-1 (AEG-1) in cervical cancer and its correlation with angiogenesis. Asian Pac J Cancer Prev. 16:2277–2281. 2015.PubMed/NCBI View Article : Google Scholar
32	Huang LL, Wang Z, Cao CJ, Ke ZF, Wang F, Wang R, Luo CQ, Lu X and Wang LT: AEG-1 associates with metastasis in papillary thyroid cancer through upregulation of MMP2/9. Int JOncol. 51:812–822. 2017.PubMed/NCBI View Article : Google Scholar